Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Cigna    CI

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

CIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With Anthem

share with twitter share with LinkedIn share with facebook
share via e-mail
02/16/2017 | 03:32pm CEST
By Brent Kendall 

A Delaware judge on Wednesday issued a temporary restraining order that blocks Cigna Corp. from immediately terminating its troubled $48 billion merger with rival health insurer Anthem Inc.

The development is the latest in what could be a long and bitter legal battle between the two companies in the wake of a federal judge's ruling earlier this month that the proposed merger violates U.S. antitrust law.

Cigna on Tuesday declared it was done with the merger and sued Anthem, seeking a $1.85 billion breakup fee plus more than $13 billion in damages from its deal partner. Anthem then responded with its own lawsuit and sought an immediate order stopping Cigna from ending their pact.

Anthem obtained such an order Wednesday from Vice Chancellor J. Travis Laster, a judge on the Delaware Chancery Court, according to a Thursday filing by Cigna with the Securities and Exchange Commission.

Under the terms of the merger agreement, Anthem could extend the deal until the end of April. The firm is making a long-shot bid to win a quick appeal of U.S. District Judge Amy Berman Jackson's ruling that the merger would unlawfully harm consumers and competition.

Both Anthem and Cigna have accused one another of violating their 2015 merger deal. Cigna said Anthem's alleged violations meant it couldn't extend the merger agreement until April. Anthem said Cigna has been engaged in a campaign to sink the deal.

Cigna in a statement said, "This is not a decision on the merits of the case, but rather a procedural order to ensure irrevocable actions do not take place before the court's substantive review of the issues. Cigna respects the court's decision and will continue to abide by terms of the merger agreement until the court further reviews the case."

The insurer said another hearing will be scheduled the week of April 10.

Anthem didn't respond to a request for comment on the restraining order.

Write to Brent Kendall at [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
ANTHEM INC 0.77% 233.65 Delayed Quote.3.05%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CIGNA
05/16MADE FOR EACH OTHER : Cigna, Express Scripts Say No Other Suitors Emerged
05/16CIGNA : Furthers its Commitment to Help Curb the National Opioid Epidemic
05/16CIGNA : Furthers its Commitment to Help Curb the National Opioid Epidemic
05/16MADE FOR EACH OTHER : Cigna, Express Scripts say no other suitors emerged
05/14U.S. to consider expanding Medicare drug price negotiation
05/09CIGNA : Named to Corporate Responsibility Magazine’s 100 Best Corporate Ci..
05/08CIGNA : New Cigna Simple File Alerts Consumers to Additional Benefit Payouts
05/07CIGNA CORPORATION : Announces Appearance at the 2018 Bank of America Merrill Lyn..
05/07CIGNA : New Cigna Simple File Alerts Consumers to Additional Benefit Payouts
05/06CIGNA : Inaugural Cigna Park Run sees massive turn out in Dubai
More news
News from SeekingAlpha
05/15Glenview added Express Scripts, exited Apple in Q1 
05/11Keeping It Simple On The Short Side 
05/08Express Scripts Vulnerable Ahead Of President Trump's New Policy Outlines 
05/03Cigna (CI) Q1 2018 Results - Earnings Call Transcript 
05/03Cigna Q1 revenues up 10%; non-GAAP EPS up 48%; updates guidance 
Financials ($)
Sales 2018 44 874 M
EBIT 2018 4 251 M
Net income 2018 3 131 M
Finance 2018 286 M
Yield 2018 0,03%
P/E ratio 2018 14,01
P/E ratio 2019 12,81
EV / Sales 2018 0,96x
EV / Sales 2019 0,85x
Capitalization 43 447 M
Duration : Period :
Cigna Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 217 $
Spread / Average Target 22%
EPS Revisions
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA-11.91%43 447
ANTHEM INC3.05%59 153
AETNA-1.98%57 907
HUMANA18.06%40 054